PYA Covid-19 Information Hub
New Webinar: Timely, Tough, or Tricky Physician Comp & FMV Topics—Changes to Commercial Reasonableness & Using Benchmark Data in 2022, Including COVID-19 Implications
Published May 26, 2022

On-Demand Webinar: Timely, Tough, or Tricky Physician Comp & FMV Topics—Changes to Commercial Reasonableness & Using Benchmark Data in 2022, Including COVID-19 Implications

To begin a dialogue on timely, but occasionally tricky topics in physician compensation and fair market value, PYA surveyed more than 30 physician compensation experts. PYA Principal Lyle Oelrich discussed the results in our ongoing webinar series. The latest installment addressed the following:

  • 2021 (and Beyond) Changes to Commercial Reasonableness
  • Using Benchmark Data in 2022, Including COVID-19 Implications

In this session, Lyle discussed the commercial reasonableness definition, meaning, and determination thereof. Additionally, he explored how to use physician compensation and productivity benchmark data, including a period impacted by COVID-19. Notably, he discussed mitigation strategies related to reliance on benchmark data in the evaluation of provider compensation.

This 30-minute webinar took place on May 26, 2022.

Resources:
Presentation Slides
White PaperInteractive Practice Aid

Be sure to view our other “Timely, Tough, or Tricky” webinars.

During this series, attendees can share questions or their experiences regarding the most pressing physician compensation and fair market value issues. Look for more sessions to come as they are formally scheduled, and we continue to collect participants’ input.

Some of our future sessions may also address:

  • Rural Physicians
  • Integration of Independent Physicians in Employment Models
  • Stark Blanket Waivers and the End of the Public Health Emergency
  • Call Coverage Compensation, Including COVID-19 Implications
  • Other Hot Topics (to be determined by webinar series participants, changes in market conditions over 2022, etc.)

If you would like assistance with commercial reasonableness or using benchmark data in 2022, or any matter involving valuation, strategy and transactions, or compliance, one of our executive contacts would be happy to assist. You may email them below, or call (800) 270-9629.

Executive Contacts

Interested in Learning More?

Sign Up for Our Insights, Including COVID-19 Bulletins!



    Select Your Subscriptions